Skip to main content
Ananda Pharma Plc logo

Ananda Pharma Plc — Investor Relations & Filings

Ticker · ANAN ISIN · GB00BDQPXQ60 LEI · 894500DFM8VOC5FW4X47 Aquis Stock Exchange Manufacturing
Open in API
Filings indexed 196 across all filing types
Latest filing 2024-02-06 Regulatory Filings
Country GB United Kingdom
Listing Aquis Stock Exchange ANAN

About Ananda Pharma Plc

https://www.anandapharma.co.uk/

Ananda Pharma Plc is a biopharmaceutical company focused on the development of regulatory-approved, cannabinoid-based medicines. The company's primary mission is to create therapies for complex, chronic inflammatory conditions with significant unmet medical needs. Its development pipeline is initially centered on treatments for inflammatory pain conditions, including Chemotherapy-Induced Peripheral Neuropathy (CIPN) and endometriosis, as well as heart failure with preserved ejection fraction (HFpEF). Ananda Pharma's approach covers the full development cycle, from identifying clinical potential and optimizing drug candidates to conducting clinical trials and securing marketing authorizations from regulators.

Recent filings

Filing Released Lang Actions
Appointment of Adviser
Regulatory Filings Classification · 98% confidence The document is a press release distributed via RNS (Reach) announcing the appointment of a new adviser to the company. It does not involve a change in the Board of Directors or senior management (which would be MANG), but rather an advisory role. Since it is a general corporate announcement regarding company operations and personnel that does not fit into specific categories like M&A, dividends, or financial reports, it falls under the RNS (Regulatory Filings) category as a general corporate announcement.
2024-02-06 English
Appointment of Scientific Advisers
Regulatory Filings Classification · 98% confidence The document is an RNS (Regulatory News Service) announcement from Ananda Developments PLC regarding the appointment of new scientific advisers. While it mentions management/advisory roles, it does not constitute a change in the Board of Directors or senior management (which would be MANG). As it is a general corporate announcement regarding operational developments that does not fit into specific categories like M&A, dividends, or financial results, it falls under the RNS regulatory filing category.
2024-01-23 English
Ananda Launches New Interactive Investor Hub
Regulatory Filings Classification · 98% confidence The document is a press release distributed via the RNS Reach service, announcing the launch of a new 'Interactive Investor Hub' for Ananda Developments PLC. It does not contain financial statements, audit reports, or specific regulatory filings, but rather serves as a corporate communication regarding investor relations infrastructure. As it does not fit into specific categories like 10-K, ER, or MANG, it falls under the general regulatory announcement/press release category.
2023-12-14 English
Quarterly Trading Statement to 31 October 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Management accounts for the quarters ended 31 July 2023 and 31 October 2023' and contains comprehensive unaudited financial statements, including a Statement of Comprehensive Income, Statement of Financial Position, and Statement of Changes in Equity. It provides substantive financial data and analysis for specific quarterly periods, fitting the definition of an Interim/Quarterly Report (IR). It is not merely an announcement of a report, as the full financial data is included within the text. Q3 2023
2023-11-29 English
Drug Supply Agreement Signed
Regulatory Filings Classification · 98% confidence The document is a regulatory announcement (RNS) from Ananda Developments PLC regarding the signing of a Drug Supply Agreement for a clinical trial. It does not fit into specific categories like financial reports, M&A, or director dealings. As it is a general corporate announcement released via a Regulatory Information Service (RNS) that does not fall into the other specialized categories, it is classified as a Regulatory Filing.
2023-11-14 English
Investor Presentation via Investor Meet Company
Investor Presentation Classification · 95% confidence The document is a short announcement (under 5,000 characters) from Ananda Developments PLC regarding an upcoming investor presentation via the 'Investor Meet Company' platform. It does not contain the presentation slides or content itself, but rather serves as a notification of the event and instructions on how to register. Following the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA) or general regulatory announcement (RNS). Given the specific nature of announcing an event/presentation, RPA is the most accurate fit.
2023-11-08 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.